A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Finding the right balance between safety and returns isn’t easy, which is why StockStory is here to help. That said, here is one low-volatility stock providing safe-and-steady growth and two that may not deliver the returns you need.
Two stocks to sell:
Regeneron (REGN)
Rolling One-Year Beta: 0.26
Founded by scientists who wanted to build a company where science could thrive, Regeneron Pharmaceuticals (NASDAQ: REGN) develops and commercializes medicines for serious diseases, with key products treating eye conditions, allergic diseases, cancer, and other disorders.
Why Does REGN Fall Short?
- The company has faced growth challenges as its 4.6% annual revenue increases over the last five years fell short of other healthcare companies
- Free cash flow margin shrank by 31.1 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive
- Eroding returns on capital suggest its historical profit centers are aging
At $820.33 per share, Regeneron trades at 12.2x forward P/E. Dive into our free research report to see why there are better opportunities than REGN.
NESR (NESR)
Rolling One-Year Beta: 0.76
Operating across 16 countries from Algeria to Indonesia, NESR (NASDAQ: NESR) provides oilfield services like hydraulic fracturing, cementing, and drilling to oil and gas companies.
Why Are We Cautious About NESR?
- Revenue base of $1.62 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale
- Costly operations and weak unit economics result in an inferior gross margin of 12.8% that must be offset through higher production volumes
- Efficiency has decreased over the last five years as its EBITDA margin fell by 74.1 percentage points
NESR is trading at $19.76 per share, or 10.8x forward P/E. To fully understand why you should be careful with NESR, check out our full research report (it’s free).
One stock to buy:
EMCOR (EME)
Rolling One-Year Beta: 0.91
Through its network of over 70 subsidiaries, EMCOR (NYSE: EME) provides electrical, mechanical, and building construction and services
Why Do We Love EME?
- Annual revenue growth of 16.3% over the past two years was outstanding, reflecting market share gains this cycle
- Performance over the past two years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Improving returns on capital reflect management’s ability to monetize investments
EMCOR’s stock price of $650.32 implies a valuation ratio of 20.1x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks we like even more
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
